1. Home
  2. LCTX vs SILC Comparison

LCTX vs SILC Comparison

Compare LCTX & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCTX
  • SILC
  • Stock Information
  • Founded
  • LCTX 1990
  • SILC 1987
  • Country
  • LCTX United States
  • SILC Israel
  • Employees
  • LCTX N/A
  • SILC N/A
  • Industry
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • SILC Computer Manufacturing
  • Sector
  • LCTX Health Care
  • SILC Technology
  • Exchange
  • LCTX Nasdaq
  • SILC Nasdaq
  • Market Cap
  • LCTX 127.7M
  • SILC 104.7M
  • IPO Year
  • LCTX N/A
  • SILC 1994
  • Fundamental
  • Price
  • LCTX $0.68
  • SILC $16.60
  • Analyst Decision
  • LCTX Strong Buy
  • SILC Hold
  • Analyst Count
  • LCTX 4
  • SILC 2
  • Target Price
  • LCTX $4.50
  • SILC N/A
  • AVG Volume (30 Days)
  • LCTX 1.2M
  • SILC 16.6K
  • Earning Date
  • LCTX 03-06-2025
  • SILC 01-30-2025
  • Dividend Yield
  • LCTX N/A
  • SILC N/A
  • EPS Growth
  • LCTX N/A
  • SILC N/A
  • EPS
  • LCTX N/A
  • SILC N/A
  • Revenue
  • LCTX $8,719,000.00
  • SILC $58,114,000.00
  • Revenue This Year
  • LCTX N/A
  • SILC $6.22
  • Revenue Next Year
  • LCTX $41.15
  • SILC $19.10
  • P/E Ratio
  • LCTX N/A
  • SILC N/A
  • Revenue Growth
  • LCTX N/A
  • SILC N/A
  • 52 Week Low
  • LCTX $0.48
  • SILC $11.35
  • 52 Week High
  • LCTX $1.61
  • SILC $18.24
  • Technical
  • Relative Strength Index (RSI)
  • LCTX 53.39
  • SILC 47.87
  • Support Level
  • LCTX $0.58
  • SILC $16.35
  • Resistance Level
  • LCTX $0.73
  • SILC $17.46
  • Average True Range (ATR)
  • LCTX 0.05
  • SILC 0.63
  • MACD
  • LCTX 0.00
  • SILC -0.09
  • Stochastic Oscillator
  • LCTX 50.67
  • SILC 17.11

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About SILC Silicom Ltd

Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters; Edge Networking Solutions; FPGA Based Cards; x86 Open Appliances Bypass Switches and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.

Share on Social Networks: